NCT03727516 (Italian-OES) is a clinical trial in Elbow Disease, sponsored by Università degli Studi di Ferrara.

Who is sponsoring NCT03727516?

NCT03727516 is sponsored by Università degli Studi di Ferrara.

What condition does NCT03727516 study?

NCT03727516 studies Elbow Disease, Patients Reported Outcomes, Elbow Surgery.

Is NCT03727516 still recruiting?

NCT03727516 is currently completed. Last updated 16 June 2020.

Last reviewed 2020-06-16 · How we verify

NCT03727516: Italian-OES

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Italian Version of the Oxford Elbow Score Score

Completed Last updated 16 June 2020

What this trial tests

trial in Elbow Disease in 110 participants. Completed in 1 March 2020.

Timeline

24 July 2018

Primary endpoint
1 March 2020

1 March 2020

Quick facts

Lead sponsor	Università degli Studi di Ferrara
Status	Completed
Study type	OBSERVATIONAL
Enrollment	110
Start date	24 July 2018
Primary completion	1 March 2020
Estimated completion	1 March 2020
Sites	2 locations across Italy

Conditions studied

Elbow Disease — all drugs for Elbow Disease →
Patients Reported Outcomes — all drugs for Patients Reported Outcomes →
Elbow Surgery — all drugs for Elbow Surgery →

Sponsor

Università degli Studi di Ferrara — full company profile →

Who can join

18 and older, any sex, with Elbow Disease or Patients Reported Outcomes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Validation of the cross-cultural adapted Italian version of the Oxford Elbow Score, in order to have an instrument able to detect the functional state reported by patients after elbow surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Validation of the cross-cultural adapted Italian version of the Oxford Elbow Score.
Padovani S, Capuzzo M, Massari L, Caruso G, et al · · 2021 · cited 5× · PMID 33681858 · DOI 10.1016/j.jseint.2020.10.025

Verify or expand the search:

Other Università degli Studi di Ferrara trials

Trials by the same sponsor.

NCT07157696 — Advanced Respiratory Monitoring and Oxygen Therapy in Chronically Ill Patients With Acute Respiratory Failure · NA · not yet recruiting
NCT06671106 — Efficacy of an Amine and Zinc Lactate - Containing Mouthrinse in the Home-based Treatment of Plaque-induced Gingivitis i · NA · recruiting
NCT06482294 — CIVETTA: Correlating Inflammatory Values of FEno, SympToms, SpuTum and Lung Function in Asthma · Phase 2 · active not recruiting
NCT06215001 — Individualized Selection of PEEP in Patients Affected by Expiratory Flow Limitation · NA · unknown
NCT06769308 — Effect of Goal-directed Analgesia and Sedation Using EEG Derived QCON/qNOX in ICU Patients · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03727516 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Università degli Studi di Ferrara
Last refreshed: 16 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03727516.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing